Aventis Menactra May Get CDC Endorsement For Teens And College Freshmen
This article was originally published in The Pink Sheet Daily
Executive Summary
The meningococcal conjugate vaccine will be provided as catch up to 11- to 18-year-olds depending on supply. CDC projects the cost of the vaccine, which could be approved this year, at $80 per dose.